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Background. Prenatal exposure to cocaine can be deleterious to embryonic brain development, but the results in humans
remain controversial, the mechanisms involved are not well understood and effective therapies are yet to be designed. We
hypothesize that some of the prenatal effects of cocaine might be related to dysregulation of physiological rhythms due to
alterations in the integrating circadian clock function. Methodology and Principle Findings. Here we introduce a new high-
throughput genetically well-characterized diurnal vertebrate model for studying the mechanisms of prenatal cocaine effects
by demonstrating reduced viability and alterations in the pattern of neuronal development following repeated cocaine
exposure in zebrafish embryos. This effect is associated with acute cocaine-induced changes in the expression of genes
affecting growth (growth hormone, zGH) and neurotransmission (dopamine transporter, zDAT). Analysis of circadian gene
expression, using quantitative real-time RT-PCR (QPCR), demonstrates that cocaine acutely and dose-dependently changes the
expression of the circadian genes (zPer-3, zBmal-1) and genes encoding melatonin receptors (zMelR) that mediate the circadian
message to the entire organism. Moreover, the effects of prenatal cocaine depend on the time of treatment, being more robust
during the day, independent of whether the embryos are raised under the light-dark cycle or in constant light. The latter
suggests involvement of the inherited circadian factors. The principal circadian hormone, melatonin, counteracts the effects of
cocaine on neuronal development and gene expression, acting via specific melatonin receptors. Conclusions/Significance.
These findings demonstrate that, in a diurnal vertebrate, prenatal cocaine can acutely dysregulate the expression of circadian
genes and those affecting melatonin signaling, growth and neurotransmission, while repeated cocaine exposure can alter
neuronal development. Daily variation in these effects of cocaine and their attenuation by melatonin suggest a potential
prophylactic or therapeutic role for circadian factors in prenatal cocaine exposure.
Citation: Shang EH, Zhdanova IV (2007) The Circadian System Is a Target and Modulator of Prenatal Cocaine Effects. PLoS ONE 2(7): e587. doi:10.1371/
journal.pone.0000587
INTRODUCTION
Tens of thousands of babies that have been exposed to cocaine in
utero are born in the United States every year [1]. Multiple human
studies suggest significant changes in brain development and
subsequent brain function in children of drug-addicted parents
[2,3]. However, the extent of the damage and whether it is in part
due to confounding environmental, genetic or psychological factors
remains controversial [4]. In contrast, studies in animal models,
including rodents and primates, clearly show that prenatal cocaine
exposure has deleterious effects on the developing brain, affecting
both cognitive functions and emotional responses [5,6].
We hypothesize that inter-individual variability in the prenatal
effects of cocaine might reflect an irregular pattern of exposure of
human embryos to cocaine, self-administered by their mothers at
different times of day, at irregular intervals and at different doses.
Such intermittent cocaine use could produce variable results in
affecting the circadian clock, known to respond differently to drugs
or environmental stimuli depending on the time of exposure [for
review, 7]. Alterations in the integrating role of the clock system
would result in mutual de-synchronization of internal physiological
processes and lack of coordination with the external, including
maternal, environment. Considering the role of the circadian
system in the control of cell division [8–10], especially important
during early development, altered clock mechanisms might lead to
multiple subtle embryonic abnormalities. While studies in rodents
suggest that the circadian system has close links to the behavioral
effects of cocaine in adults [for review, 11], no research on whether
cocaine affects the circadian-related processes during early
development has yet been done.
To address our hypothesis, we chose a popular animal model of
vertebrate development and genetics, the zebrafish. Translucent
zebrafish embryos allow for direct visual monitoring of a live and
developing vertebrate. This and genetically encoded fluorescent
reporters (e.g., green fluorescent protein, GFP) in transgenic
zebrafish provide a unique opportunity for studying expression of
specific genes throughout development. To assess potential
differences in zebrafish brain development in response to cocaine,
we have used a1-T-GFP transgenic zebrafish, with a GFP reporter
driven by the 1.696-kb goldfish a1-tubulin promoter fragment
[12]. a1-Tubulin is a neural-specific isoform of the a-tubulin
family of proteins, forming the microtubule cytoskeleton in
developing axons and dendrites [for review 13]. The reporter
recapitulates a1-tubulin endogenous gene expression and thus is
present in committed neuroprogenitors and actively developing
neurons, allowing qualitative and quantitative evaluation of the
developing brain and spinal cord [12–14].
An additional advantage of our animal model for understanding
the role of the circadian system in human physiology is that zebrafish
are diurnal vertebrates, and exhibit a temporal relationship between
circadian factors and the physiological states similar to that in
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and overall mechanisms of the circadian clock, the functional
relationship between the day/night circadian phases and the
physiological or behavioral status of the organism differs between
diurnal and nocturnal species [for review, 15]. For example, the
neuronal activity of the mammalian master clock, the suprachias-
matic nucleus of the hypothalamus (SCN), is high during the day in
both diurnal and nocturnal species. However, an exclusively
nighttime secretion of the principal hormone of the circadian system,
melatonin, coincides with active behavioral and physiological phase
in nocturnal species, while diurnal species, including humans, are at
rest or sleep when their melatonin is at peak. Accordingly, the
circadian factors, including melatonin can have distinctly different
effects in diurnal and nocturnal animals, e.g., melatonin can promote
sleep in only diurnal vertebrates [for review, 16].
Another important advantage of zebrafish for circadian-related
studies on development is that their clock mechanisms are active
early in embryogenesis, with variation in some circadian gene
expression (e.g., zPer-3) being under control of inherited factors
[17] and others requiring development of the embryonic circadian
clock [for review, 18]. In zebrafish, the principal circadian
hormone, melatonin, and its receptors are functional by the end
of the first day post-fertilization [10]. The six zebrafish melatonin
receptors identified are homologous to those found in mammals,
amphibians or birds [19]: zMel1a-1, zMel1a-2 and zMel1a-3
(corresponding to Mel1a or MT1 in other species), zMel1b-1 and
zMel1b-2 (corresponding to Mel1b or MT2), and zMel1c (Mel1c).
Early embryonic expression of functional melatoninreceptors and
their much higher levels in the embryos of several species studied,
including humans, suggest that melatonin and the overall circadian
system play an important role in development [for review, 20]. Our
earlier findingthatmelatoninpromotes zebrafishembryogenesisand
cell division [10] further supports this notion. Importantly, in
humans, maternal melatonin acting through its specific receptors
might be the principal circadian factor available to an embryo,
suggesting that alterations in melatonin levels or melatonin receptor
expression might significantly affect human development.
Here we report that prenatal exposure to cocaine, in concentra-
tions comparable to those experienced by human embryos, alters
neuronal development in zebrafish and is associated with acute
changes in the embryonic expression of mRNA for growth hormone
and the dopamine transporter. These effects of prenatal cocaine
exhibit significant circadian variation and involve changes in the
expression of the inherited and embryonic clock genes, as well as the
genes encoding melatonin receptors. Moreover, melatonin pre-
treatment attenuates or blocks the effects of cocaine on neuronal
development and embryonic gene expression. Thus, the circadian
system might be at the core of the developmental effects of cocaine
and their inter-individual variability. Circadian factors, including
melatonin, could provide new therapeutic strategies to counteract
the developmental effects of prenatal cocaine exposure.
RESULTS
Daytime cocaine exposure affects embryonic
mortality rate, neuronal development and
expression of genes responsible for growth and
neurotransmission
The choice of cocaine concentrations used in our experiments was
based on those experienced by the human fetuses of cocaine-
addicted mothers. The 0.3 mM cocaine concentration (referred to
as Low-dose Cocaine below) is similar to human plasma cocaine
levels following injection of a low 0.2 mg/kg (i.v.) cocaine dose
capable of changing mood and physiological parameters [21].
Similar maximal umbilical cord plasma cocaine levels were
documented in neonates [22], presumably hours after their
mothers self-administered cocaine.
To confirm that cocaine can be absorbed by the zebrafish
during development, cocaine levels were measured at 6 days post
fertilization (dpf). Following a single 15-min immersion in cocaine
solution, cocaine levels in larvae corresponded to 0.4–0.6 ng per
100 mg protein and 9–12 ng per 100 mg protein for the 1.5 and
30 mM doses, respectively. Measuring tissue cocaine levels in de-
chorionated zebrafish embryos was impractical due to the very
large number of subjects per sample required to achieve the assay
sensitivity threshold. The degree of cocaine absorption can be
expected to be the same or higher in the de-chorionated embryos,
compared to larvae. Based on these results, the study was conducted
inde-chorionated embryos(or larvae),mainlyusingthe 0.03–30 mM
range of cocaine doses administered via immersion.
The embryonic mortality rate was not affected following a single
15-min cocaine treatment, however it was dose-dependently
increased in de-chorionated zebrafish embryos repeatedly treated
with cocaine during the daytime (starting ZT 5, 22 hpf, 15 min
per hour for 5 hours). The higher doses of cocaine resulted in
higher mortality rate within 24-h after treatment. While in the
control de-chorionated embryos the mortality rate was 4–9 per
100 embryos, cocaine treatment increased this rate 662.1% and
3766.3% above control level following 1.5 mM and 30 mM dose,
respectively (p,0.05 for both, based on paired t-test of within
clutch comparisons, six individual clutches per treatment). An
intact chorion protected the zebrafish embryos from cocaine (no
difference from control), although cocaine could induce earlier
hatching of the embryos. The latter suggests increased cocaine
penetration during pre-hatching changes in the chorion.
Upon inspection, the surviving cocaine-treated embryos or
larvae typically showed no apparent signs of anatomical abnormal-
ities following repeated cocaine exposures (0.3, 1 or 3 mM),
compared to control. Consistent with the original observations
[12,14], a1-tubulin-associated GFP fluorescence in control a1-
TGFP zebrafish embryos was first detected 12–14 hours post
fertilization (hpf) and, within a few hours, highlighted the entire
central nervous system (CNS), thereafter peaking in different
regions in a predictable pattern. The control group showed highly
similar levels of fluorescence (Fig. 1 A–C). In contrast, cocaine-
treated embryos demonstrated multiple changes in GFP fluores-
cence, ranging from an overall reduction or, less frequently, an
overall increase in neuron-associated fluorescence. The areas
affected included the forebrain (Fig. 1 A vs. D, E), spinal cord and
enteric neurons (Fig. 1 B, C vs. F, G), with the degree varying
between and within the individual clutches of embryos. Moreover,
some of the embryos that were viable and responsive to touch
showed localized changes, with GFP signal being increased or
decreased only in some areas of the CNS, compared to control.
This suggested that the pattern of brain development has been
changed by cocaine exposure.
By the end of the first day post-fertilization, zebrafish embryos
are actively developing neuronal structures, analogous to those
targeted by cocaine in mammals, forming the dopaminergic,
serotoninergic and noradrenergic neuronal systems [23,24]. At the
same time, the circadian structures, such as the pineal gland and
retina, undergo fast growth and differentiation [25]. To address
whether cocaine-induced changes in neuronal patterns observed in
a1-TGFP embryos could involve a broader phenomenon of
growth-related processes or alterations in neurotransmission,
changes in the mRNA levels for growth hormone (zGH) and the
dopamine transporter (zDAT) were quantified. The latter gene was
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cocaine effects in adults and potentially contributes to the effects of
prenatal cocaine on reward responses during adulthood.
A single 15-min exposure to 0.3 mM cocaine at 24 hours post-
fertilization (hpf) significantly (p,0.001) altered the daytime
expression of zGH, causing a 7.5-fold upregulation (Fig. 2D). At
the same time, zDAT expression was inhibited (p,0.001) by this
dose of cocaine (Fig. 2A). In contrast, similar exposure of the
zebrafish embryos to a 100 times higher dose of cocaine (30 mM),
that increases their mortality rate, failed to produce significant
changes in the expression of both genes. It should be noted that
these and other doses used in this study did not affect the
expression of the control gene (b-actin) or total mRNA levels.
Cocaine alters the daytime expression of mRNA for
circadian genes and melatonin receptors.
A single 15-min exposure to cocaine significantly and dose-
dependently altered the daytime expression of the mRNA for the
circadian genes (zBmal-1, zPer-3) and six melatonin receptors
(zMelR) (Fig. 2). The low dose (0.3 mM) of cocaine reduced zBmal-1
and zPer-3 expression, while causing an up to 4-fold increase in
mRNAs for six zMelR genes, including Mel1a-1 (Fig. 2 B, C, E).
Similar to what was found for zGH and zDAT, increasing the
dosage reduced cocaine efficacy in changing the gene expression,
independent of the initial direction of the effect observed. For
example, the low 0.3 mM dose inhibited zPer-3 or zBmal-1
expression, with no effect of the 30 mM treatment on both genes
(Fig. 2 B–C). Similarly, the dose increase caused gradual
attenuation of cocaine-induced over-expression of all six zMelR
genes, and even reversed the response, to slight inhibition,
following exposure to the maximal, 300 mM, dose tested (Fig. 2
E, G). This effect of the higher doses was not a result of a transitory
upregulation followed by compensatory downregulation of
expression. The higher cocaine doses caused stronger inhibition
of gene expression within 5 min of administration, followed by
gradual recovery to the control levels (data not shown).
Daily variation in cocaine effects during
development
We then compared the results of daytime and nighttime prenatal
exposure to cocaine. Examination of the level and pattern of GFP
signals in the neuronal structures of the a1-TGFP zebrafish
Figure 1. Prenatal exposure to cocaine alters neuronal development in a1-TGFP transgenic zebrafish embryos. Control embryos (A: 63 hpf; B and
C: 37 hpf) show highly similar patterns of GFP reporter expression. Although major anatomical abnormalities were not found in cocaine-treated
embryos, they display variable patterns and typically lower levels of GFP reporter expression (D–G) following repeated cocaine administration (1 mM,
15 min every hour for 5 daytime hours, starting at 22–24 hpf). (C) and (G) correspond to the dotted line areas in (B) and (F), respectively, and show
GFP reporter expression in the spinal cord (sc) and enteric neurons (arrows). Note that a double string of enteric neurons, separated by a prospective
lumen, is visible in both control embryos (c) but only in one of the cocaine-treated embryos (left in F and G). (D) and (E) depict different GFP
expression patterns in the forebrain of four cocaine-treated embryos (37 hpf): lateral (D) and semi-dorsal view (e; arrowheads-eyes). All pictures are
original photographs of live, responsive-to-touch embryos of the same clutch, placed next to each other on the cover glass. Black spots in (A) and (D)
represent pigment. Out-of-focus areas on the close-up whole-embryo pictures (e.g., B, F) are due to the curved position of the embryo around the
spherical yolk sack. The pictures are from one of the 12 clutches studied in LD, and are representative of 3 independent experiments. Scale bars:
250 mm. (H and I) Mean (SEM) percent change in fluorescence intensity in the brain and spinal cord of 37 hpf embryos raised in LD (H)o rL L( I)
conditions, relative to mean Control group intensity in LD (100%). Control (white bar), repeated cocaine (1 mM) administration alone (black bar) or
with 30-min melatonin pre-treatment (diagonal bar) at 22 hpf. p,0.05 * relative to LD Control, or # relative to LL Control (one-way ANOVA), n=28
per treatment group.
doi:10.1371/journal.pone.0000587.g001
Clock and Prenatal Cocaine
PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e587following repeated nighttime cocaine treatment (0.3 or 30 mM, at
32–37 hpf) showed an improved survival rate and less variability
in GFP signal (p,0.01 and 0.0001, respectively; data not shown).
However, we had to consider that embryos were 12-h older at the
start of the nighttime treatment and the GFP signal by this time
had reached a high level in all the embryos. Considering that the
half-life of GFP is close to 24-h, these results could be significantly
affected by GFP synthesis prior to treatment and might not
necessarily reflect daily variation in the effects of cocaine. These
results are thus only suggestive of daily variation in the effects of
cocaine on neuronal development.
The effects of acute cocaine exposure on gene expression also
showed circadian variation. In contrast to the daytime effects of
cocaine described above, nighttime cocaine treatment (at 36 hpf,
ZT 19) in embryos raised in a light-dark cycle (LD) failed to
change the expression of the majority of the genes tested (Fig. 3).
The only exception was zPer-3 expression. While neither low nor
high doses of cocaine affected the daytime zPer-3 mRNA level
(Fig. 2 B), the 0.3 mM dose inhibited and 30 mM dose upregulated
it at night (Fig. 3 B).
Although the focus of this study was on the prenatal effects of
cocaine, we were concerned that fast embryonic development may
affect our daytime versus nighttime comparisons. To test this, we
assessed the effects of the daytime and nighttime cocaine
treatments (ZT 7 or 19) in 5-6-day old zebrafish larvae, at the
time when developmental processes slow down, compared to the
Figure 2. Prenatal daytime cocaine exposure dose-dependently alters expression of genes involved in neurotransmission (A) circadian system
(B, C) growth (D) and melatonin signaling (E), and these effects are counteracted by melatonin. (A–E) Melatonin (100 nM for 45 min), Low
(0.3 mM) or High (30 mM) cocaine doses (15 min), with or without melatonin pre-treatment (100 nM, 30 min). (F) Melatonin receptor antagonist
Luzindole attenuates the counteracting effects of melatonin on cocaine-induced changes in the expression of all six melatonin receptor genes; only
one (zMel1a-1) receptor shown. Treatments: luzindole 50 mM for 20 min prior to melatonin; melatonin 100 nM for 20 min prior to cocaine; cocaine
0.3 mM for 15 min. (G) Dose-dependent effects of cocaine (20 min) on melatonin receptor expression. Y axis: fold change relative to control (=1).
N=3–4 samples/treatment group, 25 embryos/sample. Mean6SEM, t-test (vs. control), * p,0.05, ** p,0.01, *** p,0.001; One way ANOVA (between
treatments), a: p,0.05, vs. cocaine-only group. Mlt-melatonin; Coc-cocaine.
doi:10.1371/journal.pone.0000587.g002
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displayed a circadian pattern of gene expression and cocaine
effects, the latter being limited to daytime, as illustrated in Figure 4
for six zMelR genes. Combined, these data suggested that nighttime
circadian factors are able to neutralize some effects of cocaine
during early zebrafish development.
Melatonin counteracts the embryonic effects of
cocaine at daytime and at night
One of the hallmarks of the nocturnal physiological environment is
the presence of the principal circadian hormone melatonin,
secreted into the blood and cerebro-spinal fluid by the pineal
gland. In zebrafish, the pineal axonal projections are among the
first to develop, with melatonin production and expression of
melatonin receptors being initiated around 18 hpf, and soon after
modulating the rate of zebrafish embryonic development and cell
division [10]. When the embryos were pre-treated with melatonin
30 min before each of the five consecutive daytime cocaine
administrations, the survival rate was improved, showing no
difference from control following 1.5 mM cocaine dose, although
remained significantly higher than in control after 30 mM cocaine
treatment (2962.7% above control; p,0.05).
Melatonin administered alone produced modest, if any, changes
in daytime expression of the genes studied (Fig. 2 A–E, first
column). However, when used as a 30-min pre-treatment,
melatonin significantly modified the acute daytime effects of
cocaine, bringing the expression levels closer to the control or
melatonin-only group (Fig. 2 A–E, column 3 and 5). Such effects of
daytime melatonin pre-treatment on gene expression were
abolished by the specific melatonin receptor antagonist, luzindole,
illustrated for zMel1a-1 (Fig. 2 F). This indicated that specific
melatonin receptors mediate this effect of melatonin.
Nighttime administration of melatonin to the embryos raised in
LD, i.e., at the time of their normal melatonin production, did not
significantly affect any of the genes studied, except for a modest
but significant decline in zGH expression (Fig. 3 D). When
melatonin was used as a pre-treatment, it did not affect gene
expression if it was not altered by nighttime cocaine, as in case of
the zDAT, zBmal-1 or six zMelR (Fig. 3 A, C, E). Both the
Figure 3. Nighttime low- or high-dose cocaine exposure fails to alter the expression of zDAT, zBmal1, zGH and melatonin receptor genes during
zebrafish development but continues to affect zPer3, and this effect is counteracted by melatonin. (A–E) Melatonin (100 nM for 45 min), Low
(0.3 mM) or High (30 mM) cocaine doses (15 min), with or without melatonin pre-treatment (100 nM, 30 min) administered to 36-hpf embryos. N=3–
4 samples/treatment group, 25 embryos per sample. Mean6SEM, t-test (vs. control), * p,0.05, ** p,0.01, *** p,0.001; One way ANOVA (between
treatments), a: p,0.05, vs. cocaine-only group. Mlt-melatonin; Coc-cocaine.
doi:10.1371/journal.pone.0000587.g003
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upregulation by a high (30 mM) cocaine dose at night were
blocked by melatonin (Fig. 3 B). Similar effects of melatonin and
their daily variation were observed in 6-day old larvae (Fig. 4 B,C).
Thus, melatonin is at least one of the nocturnal circadian factors
that can attenuate or block the effects of nighttime cocaine
administration during zebrafish development.
Circadian variation in prenatal effects of cocaine
and melatonin is preserved in the absence of
light-dark cycle and embryonic circadian system
development
It has been well established that zebrafish do not develop
embryonic circadian system while raised in either constant
darkness (DD) or constant light (LL), although both conditions
eliminate an entrainment to light-dark cycle and preserve the
inherited circadian factors [26–29]. Thus, the LL conditions
allowed us to prevent embryonic entrainment to the environmen-
tal time cues, while permitted visual inspection of the embryos,
removal of their chorion prior to treatment, and other needed
procedures to ensure high quality of the experimental sample
collected.
Importantly, while melatonin production can be preserved in
DD-raised zebrafish embryos, though lacks circadian variation, LL
conditions suppress melatonin secretion [for review, 18]. Thus, LL
allowed us to test the effects of cocaine in the absence of both the
embryonic circadian system and endogenous melatonin. However,
we had to consider that zebrafish embryos inherit some of their
circadian factors, as has been shown for zPer-3 [17], and that LL
may alter some circadian parameters. Quantification of mRNA
levels for rhythmically expressed circadian genes, zPer-3 and
zBmal-1, and six zMelR, helped to characterize the impact of
environmental illumination on the circadian system in the
embryos tested. The daytime and nighttime treatment in LL was
administered according to the parents’ LD schedule and at the
same age as in the control embryos raised in LD.
The mortality rate in control and cocaine-treated embryos
tended to be increased when the embryos were maintained in LL,
relative to LD, but the change did not reach the level of
significance (p=0.069). The GFP fluorescence intensity was lower
in LL-raised a1-TGFP zebrafish embryos. Changes in fluores-
cence signal were observed in both control (spinal cord areas only)
and cocaine-treated zebrafish, compared to LD (Fig. 1 H vs. I).
These relatively small changes, however, might be, at least in
part, due to the photobleaching effect of continuous bright light
exposure.
In control embryos raised in LL, the absolute levels and
circadian patterns of gene expression were altered, relative to LD
(Fig. 5). The diurnal variation in expression remained present,
though strongly reduced, for zPer-3 (Fig. 5 A, D), while it
disappeared for zBmal-1 (Fig. 5 B, E) and zMelR genes, including
zMel1a-1 (Fig. 5 C, F). This pattern of changes confirmed earlier
Figure 4. Daily variation in melatonin receptor expression, cocaine
efficacy and ability of melatonin to counteract the effects of cocaine
are preserved during early postnatal period in zebrafish. (A) Normal
daily pattern of mRNA expression for six melatonin receptors on Day 5,
Night 5 and Day 6 post-fertilization in Control group, fold change
expressed relative to Day 5 (=1). (B) Change in melatonin receptor
expression following Daytime cocaine administration alone (Coc) or
following melatonin pre-treatment (MLT+Coc) at 6 dpf, relative to
r
Daytime Control group (=1); (C) Change in melatonin receptor
expression following Nighttime cocaine administration alone (Coc) or
following melatonin pre-treatment (MLT+Coc) at 6 dpf, relative to
Nighttime Control group (=1). Cocaine (0.3 mM, 20 min), melatonin
pre-treatment (100 nM, 30 min prior to cocaine). Y axis: fold change
relative to corresponding control (=1). N=3–4 samples/treatment
group, 20 larvae per sample. Mean6SEM, t-test (vs. control), * p,0.05,
** p,0.01, *** p,0.001 vs. cocaine-only group; One way ANOVA.
doi:10.1371/journal.pone.0000587.g004
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circadian system but preserving an inherited zPer-3 variation in
expression [17]. In spite of such major changes in the circadian
clock in LL, the effects of cocaine continued to display circadian
variation, with only nighttime changes in zPer-3 expression (Fig. 6
A, B) and only daytime changes in zBmal-1 (data not shown) or
zMelR (Fig. 6 C, D) mRNA levels.
In LL, in the absence of endogenous melatonin production [18],
melatonin treatment augmented nighttime expression of melato-
nin receptors (Fig. 6D), suggesting that normally, in LD,
endogenous melatonin is part of the mechanism promoting
circadian variation in melatonin receptor expression. Otherwise,
the effects of melatonin in LL, whether administered alone or as
a pre-treatment, were similar to those in LD for both nighttime
and daytime administration. Accordingly, melatonin continued to
slightly downregulate zMelR in the daytime (Fig. 6C) and blocked
cocaine-induced upregulation of zPer-3 expression at night and
zMelR during the daytime (Fig. 6 B, C). Thus, daily variation in the
effects of cocaine and melatonin during early development was
preserved in the absence of the embryonic circadian system or
nighttime melatonin secretion. Considering that no environmental
circadian cues were available to the embryos raised in LL, with
temperature and other parameters being constant, it appears that
inherited circadian factors might be sufficient to modulate the
effects of cocaine and melatonin in zebrafish embryos.
DISCUSSION
Understanding the mechanisms involved in prenatal cocaine
effects and finding the means to counteract them is important for
both medical research and clinical practice. In this study we
present evidence that cocaine alters the expression of at least two
principal circadian genes of the Bmal and Per families, and genes
encoding for melatonin receptors, that mediate the circadian
message throughout the organism. This supports our original
hypothesis that prenatal effects of cocaine and their inter-
individual variability may involve the integrating circadian system,
potentially causing desynchronization of multiple developmental
events. It remains to be seen whether these effects of cocaine alter
the intrinsic clock itself or only affect the downstream circadian-
controlled processes.
The highly diverse neuronal phenotype of a1-T-GFP embryos
repeatedly treated with cocaine suggests that zebrafish neuronal
development can suffer from cocaine exposure. While this effect
varies depending on the time of treatment and melatonin pre-
treatment could to some extent attenuate it, a potential link
between the circadian effects of cocaine and neurodevelopment
remains to be fully elucidated. Considering that zebrafish, the
diurnal vertebrates with well-characterized circadian genetics and
Figure 5. Normal diurnal variation in zPer3, zBmal1 and melatonin
receptors is altered in embryos raised under constant light
conditions. Daytime increase in zPer3 expression in LD (A) is partially
preserved in LL (D; p,0.05). Daily variation in zBmal1 and zMel1a-1 (and
other melatonin receptors) is abolished in LL (B vs. E; C vs. F). Y-axis in
all plots: fold change relative to LD-Day level (=1). N=3–4 samples/
time point in LD or LL group, 25 embryos/sample. Mean6SEM, t-test, *
p,0.05, ** p,0.01, *** p,0.001 indicates difference between LD and
LL, at Day or Night, accordingly.
doi:10.1371/journal.pone.0000587.g005
Figure 6. Constant light (LL) changes embryonic gene expression and
magnitude of cocaine effects, while preserving circadian variation in
cocaine and melatonin actions. Effects of melatonin, cocaine or their
combination on gene expression display diurnal (circadian) variation in
LL, similar to that in LD (Fig. 2), for both zPer-3 (A vs. B) or melatonin
receptors (C vs. D). Treatment: Melatonin, 100 nM, 50 min or 20 min
before cocaine. Cocaine: 30 mM, 20 min. Y-axis: fold change relative to
corresponding, Day or Night, LL control (=1). N=3–4 samples/time
point in LD or LL group, 25 embryos/sample. Mean6SEM, t-test (vs.
control), * p,0.05, ** p,0.01, *** p,0.001; One way ANOVA (between
treatments), a: p,0.05, vs. other two groups.
doi:10.1371/journal.pone.0000587.g006
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can provide a useful model for addressing our hypothesis and
studying an overall impact of prenatal cocaine.
Need for repeated prenatal cocaine administration to induce
changes in neuronal pattern may reflect an accumulated toxic
effect or, if our hypothesis is correct, a more pronounced desyn-
chronization of intrinsic processes following repeated assault.
Clarifying this issue and studying microscopic changes associated
with the observed alterations in the expression of the a1-tubulin-
associated reporter will be a subject of further investigation.
Considering that neuron-specific a1-tubulin transcription spans
the entire period of neuron development, from the neuroprogeni-
tor stage to the completion of axonogenesis [12,31,32], alteration
in all or some of these stages could result in changed intensity or
patterns of fluorescence.
While changes in neuronal pattern require repeated cocaine
administration, even a single brief exposure to cocaine dramati-
cally alters the expression of growth hormone mRNA, increasing it
up to 800% in zebrafish embryos. At the same time, the expression
of the dopamine transporter gene is reduced, following brief
exposure to cocaine, to around 40% of that in the control
embryos. Considering the important and diverse roles of these two
proteins, repeated cocaine-induced changes in their expression
levels are likely to result in multifactorial effects on neuronal
development. We speculate that these changes might have
contributed to the neuronal pattern alterations in cocaine-treated
a1-T-GFP embryos.
The results of this study for the first time demonstrate that the
circadian system, embryonic and/or inherited, is not only a target
of prenatal cocaine exposure but also a modulator of prenatal
cocaine effects, with the impact of cocaine on embryonic and larval
geneexpression dependingon the time of day.Thisisconsistentwith
earlier observations on the day-night differences in the behavioral
effects of cocaine in adult invertebrates [33] and vertebrates [34,35],
either wild type or circadian gene mutants, suggesting a close link
between cocaine’s effects and the circadian clock [11].
Because poor penetration of cocaine through zebrafish chorion
requires removing a chorion under the light microscope, constant
dark conditions (DD) were not used in this study. The LL
conditions, similar to DD, prevent development of embryonic
circadian rhythms but preserve inherited circadian factors in the
absence of environmental time cues [17]. Daily variation in
cocaine effects in LL and their attenuation by the nocturnal
circadian hormone, melatonin, strongly suggest that the intrinsic
circadian factors can be sufficient to modulate the prenatal effects
of cocaine. However, the results of the experiments conducted in
LL, when bright light suppresses melatonin production, also
demonstrate that melatonin is only one of the intrinsic circadian
factors that can modulate the effects of cocaine. Other factors,
those that maintain their rhythmic function in LL and presumably
inherited by the embryo, would be the primary candidates for such
effects.
The nighttime reduction in cocaine efficacy and the ability of
melatonin to counteract the effects of cocaine on embryonic gene
expression or embryonic survival, also suggests that circadian
factors could potentially serve as preventive or therapeutic agents.
Melatonin has an impressively low toxicity, based on the lack of
side effects in animal and human studies using low or high doses of
the hormone [for review, 16]. However, its effects on human
development are virtually unknown. Further in-depth studies in
diurnal species are required to evaluate all the aspects of the
potential effects of melatonin on embryonic development and
cautious approach to using melatonin or melatonin receptor
agonists during pregnancy is advised.
A biphasic dose-dependence of cocaine effects, similar to those
observed in our study, is an interesting phenomenon repeatedly
documented in diverse experimental paradigms, although the
mechanisms involved remain to be fully understood. For example,
hippocampal long-term potentiation (LTP) in rats is not affected
by 1 or 3 mM cocaine, increased by 5 and 10 mM, with the effect
declining at 20 mM and changing to inhibition at 30 mM [36].
The results of the latter study suggested that the enhancing effects
of cocaine on LTP are primarily due to blockade of monoamine
transporters, while an inhibitory effect of high cocaine doses is
related to its blockade of sodium channels, similar to its local
anesthetic mechanism. Increased mortality rate and lack of major
changes in gene expression following high dose cocaine treatment
in our zebrafish embryos may suggest a non-specific, toxic or deep
anesthetic effect of cocaine, blunting the physiological responses to
the drug.
On the other hand, the cocaine concentrations that, according
to our study, induce maximal changes in gene expression or alter
neuronal patterns correspond to those that are experienced by the
human embryos of cocaine-addicted mothers [21,22]. This further
suggests that the powerful arsenal of methodological approaches,
and the transgenic and mutant phenotypes available for zebrafish
research, provides a promising avenue for the study of prenatal
effects of cocaine in humans. The high throughput capabilities of
this model should help in designing new therapeutic approaches to
prevent cocaine-induced developmental alterations.
MATERIALS AND METHODS
Zebrafish maintenance and embryo collection
Wild-type zebrafish (Danio rerio, wild-type AB strain) and a1-TGFP
transgenic zebrafish [12], were used in this study. The a1-TGFP
transgenic zebrafish carries a GFP reporter driven by the a1-
tubulin promoter that is expressed in actively developing neuronal
structures [12,14] fish, we developed an a1-TGFP transgenic fish
in our lab on the AB-strain genetic background, as described earlier
by Goldman and using the same construct [12]. The resulting
transgene expression exactly recapitulates the original one [12].
Adult zebrafish were raised in a 14 h light:10 h dark (LD) cycle
at 26uC in a multi-tank system (Aquaneering, San Diego, CA,
USA). Natural fertilization was scheduled at mid-day, ZT 7 (ZT0
conventionally corresponds to lights-on time) and eggs collected
within an hour after (i.e., ZT7-ZT8) were used in individual
experiments. Embryos were raised at 26uC, in 14:10 LD (700:0
lux) or in constant light (LL, 700 lux) and their ages expressed as
hours post-fertilization (hpf) or days post fertilization (dpf).
The chorions were removed 1–2 h before treatment, after
which embryos were either randomly distributed between
treatment groups or the groups were formed from the embryos
of the same clutch (imaging and mortality studies). To assess
mRNA expression levels, each sample contained 25 embryos or 20
larvae, and three samples per each treatment group were tested in
parallel. All treatment and control groups shown together were
processed simultaneously. Embryos were frozen in liquid nitrogen
15 min post-cocaine-treatment.
The experimental protocol was approved by the Boston
University Medical School Animal Care and Use Committee.
Treatments
Treatments were administrated to the embryos at 24 or 36 hours
post fertilization (hpf), at ZT 7 or ZT 19, respectively. These ages
correspond to 21 hpf and 32 hpf, respectively, when embryos are
raised at 28.5uC, [25]. Larval zebrafish were also treated at ZT 7
or ZT 19.
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(10 mM, Sigma, St. Louis, MO, USA) were prepared in water.
The actual levels of melatonin were confirmed by radioimmuno-
assay (ALPCO, Windham, NH, USA). Luzindole stock solution
(10 mM in ethanol, Sigma, St. Louis, MO, USA) was further
diluted in water (50 mM). The treatment or control solutions were
added directly into the Petri dish containing the embryos or larvae.
Image analysis of GFP fluorescence in a1-TGFP
zebrafish
For documenting the effects of cocaine on brain development,
dechorionated a1-TGFP zebrafish embryos of each clutch were
distributed between the treatment groups (30–50 embryos per
group). Using embryos of the same clutch reduced intra-group
variability in fluorescence. Embryos were raised either in LD or
LL, dechorionated and an hour later repeatedly treated for 15 min
per hour for 5 consecutive hours (starting ZT 5, at 22 hpf), being
washed out after each treatment. The embryos were then
examined at intervals after treatment for morphological abnor-
malities and GFP fluorescence intensity using a fluorescence
stereomicroscope (MZFLIII, Leica). Images were captured using
a digital camera fitted onto the microscope. Exposure parameters
were kept constant throughout each experiment. The GFP
fluorescence intensity in specific areas of the original images was
quantified using image-analysis software (Image-Pro Plus, 6.2;
Media Cybernetics, Inc., Silver Springs, MD). Comparisons were
made only between embryos of the same clutch that responded to
touch and were similarly positioned in the same field of view in the
glass-bottom culture Petri dish.
Mortality rate evaluation
Change in mortality rate was evaluated following treatments with
1.5 and 30 mM cocaine, administered repeatedly for 15 min per
hour for 5 consecutive hours (starting ZT 5, at 22 hpf, and washed
out after each treatment), with or without melatonin pre-treatment
(100 nM for 20 min). Since different clutches can show substantial
differences in survival rate, presumably due to differences in egg
quality from different zebrafish parents, paired within-clutch
comparisons were used. Prior to treatment, the embryos were
dechorionated and each clutch was divided into the control and
treatment group (50–80 embryos each). In six clutches with intact
chorion, the comparisons were conducted between the control and
30 mM cocaine treatment. The mortality rate was evaluated 24-h
after the last cocaine administration. Mortality count in the control
group was considered 100% and relative change in this parameter
was calculated for the treatment group of the same clutch. The data
presented as mean (SEM) percent change, based on the results
obtained from six individual clutches per each treatment condition.
Cocaine levels in larval zebrafish
Zebrafish larvae (40–200 per sample) were treated with cocaine for
15 or 30 min as described above. They were then washed out to
removecocainefromtheirskin.Thecontrolanimalswereexposedto
the same cocaine concentration for 3 sec and then washed out in
order to control for the residual amount of cocaine left on larval skin
following immersion. The larvae were then fast frozen by immersion
in liquid nitrogen. The tissue was homogenized in buffer (0.1 M
Sodium Acetate and Sodium Fluoride 1%) and stored at 220uC. All
the samples were then sent on dry ice to the Center of Human
Toxicology (University of Utah) for further cocaine measurements.
There, cocaine levels and those of major cocaine metabolites were
measured using 0.5 ml of each sample, followed by the addition of
0.5 ml of blank plasma and the deuterated internal standards
(cocaine-d3, benzoylecgonine-d3, and ecgonine methyl ester-d3).
Fish samples, along with the calibration standards and quality
control samples, were analyzed by solid-phase extraction, followed
by liquid chromatography-tandem mass spectrometry (LC/MS/
MS)usingaelectrosprayionizationandselected-reactionmonitoring
[37] with modifications [38]. The resulting lower limit of
quantification for each analyte was 2 ng/ml. Protein quantification
(BCA Protein Assay, Pierce Biotechnology, Rockford IL, USA) was
done for further normalization of cocaine levels measured and the
levels are expressed per 100 mgp r o t e i n .
Total RNA extraction and cDNA synthesis
25 embryos or 20 larvae were pooled as one replicate sample
(N=3–4 per treatment group), and total RNA was extracted from
each replicate using the SV total RNA isolation system (Promega,
Madison, WI, USA), according to the manufacturer’s protocol.
The quantity and quality of RNA was determined spectrophoto-
metrically at 260 nm and 260 nm/280 nm. Same amount of
RNA from each sample was converted into cDNA using High-
Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA,
USA), according to the manufacturer’s instruction.
Real-time RT-PCR reagents and cycling
Real time quantitative PCR was performed using a TaqMan
H
Universal PCR Master Mix (ABI, Foster City, CA, USA) and an
ABI Prism 7300 Real Time PCR System (ABI, Foster City, CA,
USA). TaqMan
H probes and primers were designed based on
previously reported melatonin sequences of zebrafish and obtained
from ABI. The following primers were used:
zMel1a1, Forward,59-CTGGTGATTTTCTCCGTCTACAGA-
39, Reverse, 59-CCGCCACTGCCAAACTC-39;zMel1a-2,F o r -
ward, 59-TTGGTCATTGTGTCAGTCTTCAGAA-39, Reverse,
59-GCTATAGCCAAACTCACCACAAAG-39; zMel1a-3,F o r -
ward, 59-TTGGTGATCTTCTCCGTCTACAGA-39,R e v e r s e ,
59-TCAGCTACGGCCAGACTCA-39; zMel1b-1,F o r w a r d ,5 9-
TCGGTGTTCAGGAATCGTAAACTG-39,R e v e r s e ,5 9-GAAG-
GCCAGACTGACCACAAA-39; zMel1b-2,F o r w a r d ,5 9-TCGG-
TGCTCCGAAATAGAAAACTC-39, Reverse, 59-CGAATGCC-
AGACTTACTACAAATGC-39; zMel1c,F o r w a r d ,5 9-CCGTCTA-
CAGGAACAAGAAACTGA-39,R e v e r s e ,5 9-GGTCAGCCACA-
GAAAGACTCA-39; zPer3,F o r w a r d ,5 9-CGACTGCCATCCTG-
GAACTT-39, Reverse, 59-GATTTGACCTGCGCACATTCA-39;
zGH,, Forward, 59- GACGGGAAAAGATGAAACGCAAAA-39,
Reverse,59-TCAATGAGGCGGAAAGAGATACG-39; zDAT,,
Forward, 59-GTCTGGAAGATCTGCCCCATATT-39, Reverse,
59- CACATACAGCGAGATCAGGATCAC-39; zBmal1, Forward,
59-CAGAGCTTCGCCACAAACC-39,R e v e r s e ,5 9-CTGTGAT-
CAATGCATGTCCTTTCA-39; b-actin,F o r w a r d ,5 9-GCTGTTT-
TCCCCTCCATTGTTG-39,R e v e r s e ,5 9-TTTCTGTCCCATG-
CCAACCAT-39. Gene expression was normalized using a zebrafish
b-actin expression level. Each reaction (in triplicate) contained 10 ml
TaqMan
H Universal PCR Master Mix, 1 ml2 0 6TaqMan
H gene
Expression AssayMix (containing bothprimersand probes)and 9 ml
cDNA diluted in RNase-free water.
Statistical analysis
RT-PCR data from 3–4 independent samples per treatment group
or control were analyzed and fold change was calculated using
formula, Fold change=2
2g(gCT), where gCT=C T(target)-
CT(b-actin) and g(gCT)=gCT(stimulated)-gCT(control). Student’s
t-tests were used to test the null hypothesis that there was no
significant difference between treatment group and control group.
The results based on the within-clutch comparisons, e.g., for
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test. One-way analysis of variance (ANOVA) was used to compare
fluorescenceintensityorgeneexpressionbetweendifferenttreatment
groups (within each clutch). If significant differences were detected,
a Tukey’s post-hoc comparison was employed (SPSS, Inc.). In all
tests, difference was considered significant if p,0.05.
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